Better Coronavirus Stock: Moderna or Novavax?
Half a dozen COVID-19 vaccine candidates are currently in clinical testing. Moderna (NASDAQ: MRNA) and Novavax (NASDAQ: NVAX) claim two of them.
Unsurprisingly, both biotech stocks have skyrocketed in recent months. Moderna has arguably attracted more attention. However, Novavax has been the bigger winner with its shares rising nearly five times more than Moderna's so far in 2020. Which of these coronavirus-focused stocks is the better pick going forward?
Image source: Getty Images.
Source Fool.com
